Department of Health website

Skip to Main Content
Sitemap

Interim Guidelines on the COVID-19 Disease Severity Classification and Management
Interim Guidelines for 2019-nCoV ARD Response in Schools and HEIs
Guidelines on the Management and Administration of the Initial 600,000 Donated SARS COV-2 Vaccine (Vero Cell) Inactivated CoronoVac (Sinovac) Doses
Directive for the Continuous Operation of Dialysis Facilities in the Philippines During the Enhanced Community Quarantine in Light of the Coronavirus Disease 2019 (COVID-19) Outbreak
Implementing Guidelines for Priority Groups A4, A5 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines
Guidelines on Cleaning and Disinfection in Various Settings as an Infection Prevention and Control Measure Against COVID-19
Guidelines on the use of self-administered antigen testing for COVID-19
Reiteration of the Amendment of the Updated List of the Price Freeze of Essential Emegency Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event
Department Memorandum No. 2022-0411 "Guidelines Relative to Ramping up of COVID-19 Contact Tracing and Testing"
Interim Guidelines on the Continuous Provision of Maternal Health Services during COVID-19 Pandemic
Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event
Interim Guidelines on the Activation of 5 DOH Subnational Laboratories for the 2019-nCoV
Interim Omnibus Guidelines for the Implementation of the National Vaccine Deployment Plan for COVID-19
Interim Guidelines on Harmonized and Daily Health Facility Reporting of COVID-19-Related Essential Resources and Supplies Using the DataCollect Application
Procedures on the Procurement and Distribution of COVID-19 Vaccines for Private Entities
Proper Handling of the Remains of Suspect, Probable, and Confirmed COVID-19 Cases
Interim guidelines on the management and administration of Tozinameran COVID-19 mRNA vaccine (nucleoside-modified) [Cominarty] Pfizer COVID-19 vaccine to pediatric population ages 5-11 years old
Guidelines in the Interim Use of the Laboratories of the National TB Control Program as COVID-19 Testing Laboratories Performing Rapid PCR Testing for SARS-CoV-2
Updated Guidelines on the Minimum Public Health Standards for the Continued Safe Reopening of Institutions
Guidelines in the Certification of LIGTAS COVID Community Isolation Units
Minimum Data Requirements of COVID-19-related Information Systems
Interim Guidelines for 2019-nCoV ARD Response in Hospitals and Other Health Facilities
Interim Guidelines for the Management and Administration of the AstraZeneca (ChAdOx1-S [recombinant]) COVID-19 Vaccine
Guidance on Use of COVID-19 Rapid Antibody-based Test Kits
Guidelines for the Management and administration of COVID-19 mRNA Vaccine (Nucleoside Modified) Moderna COVID-19 Vaccine
Interim Guidelines on Management for the National Capital Region Mega Temporary Treatment and Monitoring Facilities in the Philippine International Convention Center, World Trade Center, Rizal Memorial Coliseum, Ninoy Aquino Stadium and Philippine Arena
Adjustments in Maximum Retail Price (MRP) regulation of certain medicines that are covered by Executive Order No. 155 pursuant to exemption from Value Added Tax (VAT)
Interim Guidelines on the Zoning of COVID-19 Laboratories
Department Memorandum No. 2022-0204 "Guidelines on the Shifting from Pneumococcal Conjugate Vaccine 13 (PCV13) to Pneumococcal Conjugate Vaccine 10 (PCV10) in the Routine Immunization for Children"
Endorsement of the DILG Memorandum "Updated Contact Tracing Report Template for the Coronavirus Disease 2019 (COVID-19) Situation" dated May 26, 2020

Pages